Indrayani Biotech Limited (BOM:526445)
India
· Delayed Price · Currency is INR 17.64
-0.36 (-2.00%)
At close: May 6, 2025
Indrayani Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | 63.65 | 87.37 | 43.93 | -112.14 | - | Upgrade
|
| Depreciation & Amortization | 38.05 | 33.47 | 6.59 | 4.58 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 5 | - | 20.97 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.03 | - | Upgrade
|
| Other Operating Activities | 138.9 | 87.18 | 19.11 | 19.65 | - | Upgrade
|
| Change in Accounts Receivable | -95.57 | -158.73 | -93.33 | 22.77 | - | Upgrade
|
| Change in Inventory | -301.37 | -106.82 | -4.43 | 39.82 | - | Upgrade
|
| Change in Accounts Payable | 146.52 | 169.18 | 24.77 | -29.21 | - | Upgrade
|
| Change in Other Net Operating Assets | -293.72 | 45.22 | 44.46 | 36.09 | - | Upgrade
|
| Operating Cash Flow | -303.54 | 161.88 | 41.11 | 2.56 | - | Upgrade
|
| Operating Cash Flow Growth | - | 293.76% | 1506.49% | - | - | Upgrade
|
| Capital Expenditures | -164.87 | -215.28 | -11.89 | -6.96 | - | Upgrade
|
| Sale of Property, Plant & Equipment | 0.66 | - | - | 0.12 | - | Upgrade
|
| Cash Acquisitions | - | -195.21 | -0.18 | 0.01 | - | Upgrade
|
| Investment in Securities | - | -2.23 | - | - | - | Upgrade
|
| Investing Cash Flow | -163.39 | -473.94 | -5.58 | -7.02 | - | Upgrade
|
| Long-Term Debt Issued | 372.26 | 225.85 | 5.5 | 12.1 | - | Upgrade
|
| Long-Term Debt Repaid | -8.48 | -4.63 | -13.69 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 363.78 | 221.22 | -8.19 | 12.1 | - | Upgrade
|
| Issuance of Common Stock | 46.33 | 232.82 | - | - | - | Upgrade
|
| Other Financing Activities | 32.28 | -126.64 | -19.11 | -14.87 | - | Upgrade
|
| Financing Cash Flow | 442.39 | 327.39 | -27.3 | -2.77 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | -1.43 | 0 | - | Upgrade
|
| Net Cash Flow | -24.55 | 15.33 | 6.8 | -7.23 | - | Upgrade
|
| Free Cash Flow | -468.41 | -53.4 | 29.22 | -4.4 | - | Upgrade
|
| Free Cash Flow Margin | -28.18% | -3.28% | 4.75% | -2.08% | - | Upgrade
|
| Free Cash Flow Per Share | -12.03 | -1.23 | 0.85 | -0.12 | - | Upgrade
|
| Cash Interest Paid | 98.83 | 55.57 | 18.8 | 19.61 | - | Upgrade
|
| Levered Free Cash Flow | -480.41 | -301.61 | -31.24 | 21.16 | - | Upgrade
|
| Unlevered Free Cash Flow | -418.65 | -270.36 | -19.82 | 33.09 | - | Upgrade
|
| Change in Net Working Capital | 420.94 | 180.3 | 53.39 | -68.62 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.